Showing results (21-30 of 197) with videos related to
Sort By:
Pageof 20
Pathologist|May 11, 1983
Selecting instrumentation and reagents for the coagulation laboratoryJ Wujastyk, D A TriplettLa Ricerca in Clinica E in Laboratorio|October 1, 1989
Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutionsL Barna, D A TriplettAmerican Journal of Clinical Pathology|May 1, 1991
Serologic characterization of Rocky Mountain spotted fever. Appearance of antibodies reactive with endothelial cells and phospholipids, and factors that alter protein C activation and prostacyclin secretionT S Walker, D A TriplettAnnals of Diagnostic Pathology|July 4, 2001
When to suspect hypercoagulability and how to investigate itM B Marques, D A TriplettHematologic Pathology|January 1, 1988
Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenonD A Triplett, J T BrandtArchives of Pathology & Laboratory Medicine|December 1, 1989
The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom timeJ T Brandt, D A TriplettAmerican Journal of Clinical Pathology|October 1, 1982
Factor XI assay results in the CAP survey (1981)R W Pearson, D A TriplettAmerican Journal of Clinical Pathology|August 1, 1979
Cap survey results for factor VIII assays (1977-1978)T A Kocoshis, D A TriplettAmerican Journal of Clinical Pathology|October 1, 1983
Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982)R L Christensen, D A TriplettAmerican Journal of Hematology|September 21, 2000
Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS)D A Triplett, R A AshersonPageof 20